Wealth Daily Articles
[Filters]Displaying (9602) Articles
Lithium Miner Reaches Deal with Japanese Company
Brian HicksPosted January 14, 2013
Lithium miner Canada Lithium (TSX: CLQ) has reached a three year agreement with a Japanese commodity trader.
This Is Food Stamp Lunacy
Jeff SiegelPosted January 12, 2013
One college grad talks about the sacrifices he made to repay his debt in two years. But taking food stamps is NOT a sacrifice.
Second Amendment Attacks Continue
Jeff SiegelPosted January 12, 2013
A handful of Illinois lawmakers recently passed a measure that would ban all semi-automatic rifles and handguns.
California Pharmaceutical Company Acquires Biotech
Brian HicksPosted January 11, 2013
BioMarin (NASDAQ: BMRN) has acquired Zacharon Pharmaceuticals to help with genetic disease drug research.
Mining Robotics
Brian HicksPosted January 11, 2013
In a partnership with Carnegie Mellon University, miner Anglo American (LON: AAL) is developing robotic technology to aid mining efforts.
2 Data Points and 3 Trends for Q1
Christian DeHaemerPosted January 10, 2013
For the first time in three years, consumer credit card debt has improved for three consecutive quarters. Less debt means more disposable income.
Gold Attractive in Economic Uncertainty
Brian HicksPosted January 10, 2013
As the debt ceiling approaches as the next major deadline for U.S. lawmakers, gold remains a strong safe haven.
Silver ETFs Gain
Brian HicksPosted January 10, 2013
Silver prices were lackluster in December 2012, but net inflows into silver ETFs gained in that period.
Coal's New Life Overseas
Adam EnglishPosted January 9, 2013
King Coal has been dethroned and is being ran out of America. However, coal still rules supreme overseas, and American miners are poised to make a fortune.
African Barrick Gold (LON: ABG) Sale Falls Through
Brian HicksPosted January 9, 2013
After sale talks between Barrick Gold (TSX: ABX) and China National Gold Group fell through, African Barrick Gold (LON: ABG) shares dropped.
Biotech Collaborates with Startup on Cancer Drug
Brian HicksPosted January 9, 2013
Major biotech Amgen (NASDAQ: AMGN) is working with a startup to create a drug targeting cancer cells.
Buy This Stock
Christian DeHaemerPosted January 8, 2013
Should you own this stock? Heck ya! Christian DeHaemer explains why this company is a great investment for the year to come.
© WEALTH DAILY. ALL RIGHTS RESERVED.